Timothy M. Shannon, Director at CytomX Therapeutics, Inc. (CTMX), sold 44,172 shares at $11.18 ($494K) on 2016-11-29, disclosed to the SEC on 2016-12-01.
Open-market sale of $494k CTMX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.18 | 22,086 | $247K | 50.0% |
| 2 | $11.18 | 22,086 | $247K | 50.0% |
| Total | $11.18 avg | 44,172 | $494K | 100% |
| Filing → |
| ARVN | SELL | 2021-09-27 | $4.3M | — | Filing → |
| ARVN | SELL | 2021-09-27 | $32.9M | — | Filing → |
| RLYB | BUY | 2021-08-04 | $1000K | — | Filing → |